1 – 50 of 67
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis : a cohort study
(
- Contribution to journal › Article
- 2023
-
Mark
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
(
- Contribution to journal › Article
-
Mark
Radiographic damage in early rheumatoid arthritis is associated with increased disability but not with pain-a 5-year follow-up study
(
- Contribution to journal › Article
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
(
- Contribution to journal › Article
-
Mark
Diet and the risk of rheumatoid arthritis- a systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients
2023) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
(
- Contribution to journal › Article
-
Mark
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis-results from a nested case-control study
2023) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Cardiovascular disease risk in early rheumatoid arthritis : the impact of cartilage oligomeric matrix protein (COMP) and disease activity
(
- Contribution to journal › Article
- 2022
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Pathogenesis of giant cell arteritis with focus on cellular populations
(
- Contribution to journal › Scientific review
-
Mark
LEVELS OF IL-6 AND OTHER INFLAMMATORY PROTEINS IN EARLY RA PREDICT JOINT DAMAGE PROGRESSION OVER 5 YEARS
(
- Contribution to journal › Published meeting abstract
-
Mark
An update on polymyalgia rheumatica
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
(
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Proteomic data analysis for differential profiling of the autoimmune diseases SLE, RA, SS, and ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study
(
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
(
- Contribution to journal › Article
-
Mark
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden : From infection severity to impact on care provision
(
- Contribution to journal › Article
-
Mark
Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study
(
- Contribution to journal › Article
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
- 2020
-
Mark
Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
(
- Contribution to journal › Article
-
Mark
EULAR/eumusc.net standards of care for rheumatoid arthritis : cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
(
- Contribution to journal › Article
-
Mark
Abatacept in rheumatoid arthritis : Survival on drug, clinical outcomes, and their predictors - Data from a large national quality register
(
- Contribution to journal › Article
-
Mark
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica : A systematic literature review
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Lower extremity function in patients with early rheumatoid arthritis during the first five years, and relation to other disease parameters
(
- Contribution to journal › Article
-
Mark
PREVALENCE OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN SOUTHERN SWEDEN
(
- Contribution to journal › Published meeting abstract
-
Mark
Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : Results from the nationwide Swedish register
(
- Contribution to journal › Article
-
Mark
Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
(
- Contribution to journal › Scientific review
-
Mark
Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care
(
- Contribution to journal › Article
-
Mark
PREDICTORS OF EROSION AND JOINT SPACE NARROWING PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
(
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
The risk of clinically diagnosed gout by serum urate levels : Results from 30 years follow-up of the Malmö preventive project cohort in southern Sweden
(
- Contribution to journal › Article
-
Mark
Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Incidence And Seasonal Variation Of Biopsy-Proven Giant Cell Arteritis – Revisited: A 20-Year Population-Based Study From Sweden
2018) American College of Rheumatology (ACR) Annual Meeting In Arthritis & Rheumatology 70(Suppl 9).(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Severe extraarticular manifestations in a community based cohort of patients with rheumatoid arthritis : Risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy : A prospective observational study of patients registered in the south Swedish SSATG registry
(
- Contribution to journal › Article
-
Mark
Large vessel involvement in biopsy-proven giant cell arteritis : incidence, distribution, and predictors
(
- Contribution to journal › Article
- 2016
-
Mark
Mortality in ankylosing spondylitis: results from a nationwide population-based study.
(
- Contribution to journal › Article
-
Mark
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.
(
- Contribution to journal › Article
-
Mark
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent : Trajectories of Disease Activity in a Large Multinational Cohort Study
(
- Contribution to journal › Article
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
(
- Contribution to journal › Article
-
Mark
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
(
- Contribution to journal › Article